We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$33.1B
AUM Growth
+$1.62B
Cap. Flow
+$885M
Cap. Flow %
2.67%
Top 10 Hldgs %
37%
Holding
1,568
New
69
Increased
691
Reduced
367
Closed
73

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$864M
2
BAC icon
Bank of America
BAC
+$84.7M
3
EW icon
Edwards Lifesciences
EW
+$69M
4
BABA icon
Alibaba
BABA
+$65.5M
5
AMD icon
Advanced Micro Devices
AMD
+$56.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$83.9M
2
TYL icon
Tyler Technologies
TYL
+$73.9M
3
CNM icon
Core & Main
CNM
+$73M
4
ITRI icon
Itron
ITRI
+$71.3M
5
UBER icon
Uber
UBER
+$70.5M

Sector Composition

Rank Sector Weight
1 Technology 36.91%
2 Healthcare 15.81%
3 Financials 12.06%
4 Communication Services 11.11%
5 Consumer Discretionary 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
901
Lantheus
LNTH
$6.59B
$1.38M ﹤0.01%
20,700
+2,300
+13% +$134K
CRNX icon
902
Crinetics Pharmaceuticals
CRNX
$8.96B
$1.37M ﹤0.01%
29,500
-2,600
-8% -$116K
WK icon
903
Workiva
WK
$4.01B
$1.37M ﹤0.01%
15,895
-5,800
-27% -$514K
ASO icon
904
Academy Sports + Outdoors
ASO
$3.03B
$1.37M ﹤0.01%
27,400
+8,200
+43% +$407K
CORZ icon
905
Core Scientific
CORZ
$6.36B
$1.37M ﹤0.01%
93,800
+27,800
+42% +$485K
URBN icon
906
Urban Outfitters
URBN
$6.53B
$1.37M ﹤0.01%
18,153
AX icon
907
Axos Financial
AX
$5.72B
$1.35M ﹤0.01%
15,695
HOMB icon
908
Home BancShares
HOMB
$6.27B
$1.35M ﹤0.01%
48,555
BBWI icon
909
Bath & Body Works
BBWI
$3.76B
$1.35M ﹤0.01%
67,149
-2,000
-3% -$44.2K
TMDX icon
910
Transmedics
TMDX
$3.11B
$1.34M ﹤0.01%
11,000
XENE icon
911
Xenon Pharmaceuticals
XENE
$6.21B
$1.34M ﹤0.01%
29,800
+7,100
+31% +$298K
LIF
912
Life360
LIF
$4.09B
$1.33M ﹤0.01%
+20,800
New +$1.73M
LEU icon
913
Centrus Energy
LEU
$3.83B
$1.33M ﹤0.01%
+5,480
New +$1.65M
CDTX
914
DELISTED
Cidara Therapeutics
CDTX
$1.32M ﹤0.01%
+6,000
New +$970K
KTB icon
915
Kontoor Brands
KTB
$4.65B
$1.32M ﹤0.01%
21,692
+5,600
+35% +$416K
BC icon
916
Brunswick
BC
$5.29B
$1.32M ﹤0.01%
17,800
BOX icon
917
Box
BOX
$4.66B
$1.31M ﹤0.01%
43,953
INFY icon
918
Infosys
INFY
$50.3B
$1.31M ﹤0.01%
73,794
+13,794
+23% +$239K
KRC icon
919
Kilroy Realty
KRC
$4.3B
$1.31M ﹤0.01%
35,174
NVST icon
920
Envista
NVST
$4.51B
$1.31M ﹤0.01%
60,400
+11,300
+23% +$232K
QS icon
921
QuantumScape Corp
QS
$3.79B
$1.31M ﹤0.01%
125,800
-28,800
-19% -$397K
RDN icon
922
Radian Group
RDN
$4.92B
$1.31M ﹤0.01%
36,385
SLM icon
923
SLM Corp
SLM
$5.22B
$1.31M ﹤0.01%
48,379
HAYW icon
924
Hayward Holdings
HAYW
$3.24B
$1.31M ﹤0.01%
84,500
+34,900
+70% +$552K
AUR icon
925
Aurora
AUR
$13.4B
$1.3M ﹤0.01%
337,900
+50,900
+18% +$233K

Similar funds

Handelsbanken Fonder's Q4 2025 Portfolio in Review

As of Q4 2025, Handelsbanken Fonder held 1,568 positions worth $33.1B, up 5.1% from $31.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Handelsbanken Fonder's Q4 2025 filing shows 69 new, 691 increased, 367 reduced and 73 closed positions. Its largest new stake was Fluence Energy: 857,654 shares worth $17M. The largest sale was Eli Lilly, an estimated $83.9M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Financials.

  • Handelsbanken Fonder's largest Q4 2025 buy was Fluence Energy: 857,654 shares worth $17M.
  • Handelsbanken Fonder added most to Amazon in Q4 2025, an estimated $864M increase.
  • Handelsbanken Fonder's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $83.9M.
  • Handelsbanken Fonder fully exited Kellanova in Q4 2025, selling an estimated $26M.
  • Handelsbanken Fonder's ten largest holdings make up 37% of its $33.1B portfolio in Q4 2025.
  • Handelsbanken Fonder opened 69 new positions and closed 73 in Q4 2025.
  • Handelsbanken Fonder's portfolio value rose 5.1% quarter-over-quarter to $33.1B.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.